ArticlePLoS pathogens2020

Site-directed M2 proton channel inhibitors enable synergistic combination therapy for rimantadine-resistant pandemic influenza.

Claire Scott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.